EMA Stands Firm on PK Studies for Insulin Biosimilars

Drug Industry Daily
A A
The European Medicines Agency has rejected calls from industry to use biosimilar reference products from outside the EU unless they are justified using pharmacokinetic tests.

To View This Article:

Login

Subscribe To Drug Industry Daily